Page last updated: 2024-10-17

salicylic acid and Kawasaki Disease

salicylic acid has been researched along with Kawasaki Disease in 4 studies

Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).

Research Excerpts

ExcerptRelevanceReference
" Duration of fever, SGPT, serum salicylate, plasma thromboxane B2 (TxB2) and 6-keto-prostaglandin F1 alpha (PGF1 alpha) levels were compared before enrollment and on days 4, 7 and 14 of treatment."5.07Salicylate treatment in Kawasaki disease: high dose or low dose? ( Akagi, T; Inoue, O; Kato, H; Sato, N, 1991)
"We described the pharmacokinetics of acetylsalicylic acid and salicylic acid in 5 children with prior Kawasaki disease receiving buffered aspirin tablets or intravenous aspirin DL-lysine."3.68Disposition of single-dose intravenous and oral aspirin in children. ( Ito, S; Oka, R; Tsuchida, A; Yoshioka, H, 1991)
"8 years (range 8 months to 8 years), who had Kawasaki disease treated with acetylsalicylic acid (ASA) 30 to 180 mg/kg."3.67Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease. ( Koren, G; MacLeod, SM, 1984)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chua, PK1
Yanagihara, R1
Melish, ME1
Nerurkar, VR1
Koren, G1
MacLeod, SM1
Ito, S1
Oka, R1
Tsuchida, A1
Yoshioka, H1
Akagi, T1
Kato, H1
Inoue, O1
Sato, N1

Trials

1 trial available for salicylic acid and Kawasaki Disease

ArticleYear
Salicylate treatment in Kawasaki disease: high dose or low dose?
    European journal of pediatrics, 1991, Volume: 150, Issue:9

    Topics: 6-Ketoprostaglandin F1 alpha; Alanine Transaminase; Child, Preschool; Dose-Response Relationship, Dr

1991

Other Studies

3 other studies available for salicylic acid and Kawasaki Disease

ArticleYear
Modulation of adhesion molecules and monocyte chemoattractant protein by tumor necrosis factor-alpha and salicylic acid in primary human coronary artery endothelial cells.
    Cellular and molecular biology (Noisy-le-Grand, France), 2003, Volume: 49, Issue:7

    Topics: Cell Adhesion Molecules; Cells, Cultured; Coronary Vessels; Endothelial Cells; Humans; Monocyte Chem

2003
Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease.
    The Journal of pediatrics, 1984, Volume: 105, Issue:6

    Topics: Aspirin; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Mu

1984
Disposition of single-dose intravenous and oral aspirin in children.
    Developmental pharmacology and therapeutics, 1991, Volume: 17, Issue:3-4

    Topics: Absorption; Administration, Oral; Aspirin; Biological Availability; Buffers; Child, Preschool; Drug

1991